{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:06:56Z","timestamp":1790676416531,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ebiom.2022.104056","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T17:54:33Z","timestamp":1652896473000},"page":"104056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-6389","authenticated-orcid":false,"given":"Zeina","family":"Nehme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9291-797X","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Pasquereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5375-0874","authenticated-orcid":false,"given":"Sandy","family":"Haidar Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2984-5870","authenticated-orcid":false,"given":"Ranim","family":"El Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Herbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2022.104056_bib0001","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000322141","article-title":"Human cytomegalovirus (HCMV) \u2013 revised*","volume":"37","author":"Schottstedt","year":"2010","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.ebiom.2022.104056_bib0002","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2022.104056_bib0003","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/v10080408","article-title":"The human cytomegalovirus, from oncomodulation to oncogenesis","volume":"10","author":"Herbein","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.ebiom.2022.104056_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/neo.81178","article-title":"The story of human cytomegalovirus and cancer: increasing evidence and open questions","volume":"11","author":"Michaelis","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.ebiom.2022.104056_bib0005","doi-asserted-by":"crossref","first-page":"e56795","DOI":"10.1371\/journal.pone.0056795","article-title":"High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes","volume":"8","author":"Taher","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ebiom.2022.104056_bib0006","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1016\/j.clbc.2017.10.018","article-title":"Detection of human cytomegalovirus in malignant and benign breast tumors in egyptian women","volume":"18","author":"El Shazly","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.ebiom.2022.104056_bib0007","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.tranon.2014.09.008","article-title":"High prevalence of human cytomegalovirus in brain metastases of patients with primary breast and colorectal cancers","volume":"7","author":"Taher","year":"2014","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ebiom.2022.104056_bib0008","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/pathogens10060641","article-title":"Productive infection of human breast cancer cell lines with human cytomegalovirus (HCMV)","volume":"10","author":"Branch","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.ebiom.2022.104056_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2018.07.004","article-title":"The dualistic origin of human tumors","volume":"53","author":"Liu","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.ebiom.2022.104056_bib0010","article-title":"High migration and invasion ability of PGCCs and their daughter cells associated with the nuclear localization of S100A10 modified by SUMOylation","volume":"9","author":"Zhao","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ebiom.2022.104056_bib0011","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7150\/ijbs.51458","article-title":"MYC dysfunction modulates stemness and tumorigenesis in breast cancer","volume":"17","author":"Liu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.ebiom.2022.104056_bib0012","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/bs.acr.2020.03.001","article-title":"Giants and monsters: unexpected characters in the story of cancer recurrence","volume":"148","author":"White-Gilbertson","year":"2020","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.ebiom.2022.104056_bib0013","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/pros.23877","article-title":"Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance","volume":"79","author":"Amend","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.ebiom.2022.104056_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.567116","article-title":"Polyploid giant cancer cells, a hallmark of oncoviruses and a new therapeutic challenge","volume":"10","author":"Herbein","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ebiom.2022.104056_bib0015","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2022.104056_bib0016","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2022.104056_bib0017","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3390\/ijms18081657","article-title":"Polycomb repressor complex 2 in genomic instability and cancer","volume":"18","author":"Veneti","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2022.104056_bib0018","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13000-016-0491-5","article-title":"EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features","volume":"11","author":"Guo","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.ebiom.2022.104056_bib0019","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells","volume":"100","author":"Kleer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2022.104056_bib0020","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1073\/pnas.1308953111","article-title":"EZH2 expands breast stem cells through activation of NOTCH1 signaling","volume":"111","author":"Gonzalez","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.ebiom.2022.104056_bib0021","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ccr.2010.10.035","article-title":"EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-\u03b2-catenin signaling","volume":"19","author":"Chang","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2022.104056_bib0022","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3892\/or.2015.4003","article-title":"The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer","volume":"34","author":"Wu","year":"2015","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ebiom.2022.104056_bib0023","doi-asserted-by":"crossref","first-page":"669","DOI":"10.18632\/oncotarget.327","article-title":"Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and post-transcriptional mechanisms","volume":"2","author":"Koh","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2022.104056_bib0024","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4161\/epi.27957","article-title":"Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression","volume":"9","author":"Kuser-Abali","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.ebiom.2022.104056_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003366","article-title":"Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) Monocytes and CD34 (+) cells","volume":"9","author":"Rossetto","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2022.104056_bib0026","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12032-014-0252-9","article-title":"Overexpression of enhancer of zeste human homolog 2 (EZH2) gene in human cytomegalovirus positive glioblastoma multiforme tissues","volume":"31","author":"Ahani","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.ebiom.2022.104056_bib0027","doi-asserted-by":"crossref","first-page":"e80120","DOI":"10.1371\/journal.pone.0080120","article-title":"iTRAQ-based proteomic analysis of polyploid giant cancer cells and budding progeny cells reveals several distinct pathways for ovarian cancer development","volume":"8","author":"Zhang","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ebiom.2022.104056_bib0028","article-title":"Number of polyploid giant cancer cells and expression of EZH2 are associated with VM formation and tumor grade in human ovarian tumor","volume":"2014","author":"Zhang","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.ebiom.2022.104056_bib0029","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1038\/s41388-021-01715-7","article-title":"Polyploid giant cancer cells, stemness and epithelial-mesenchymal plasticity elicited by human cytomegalovirus","volume":"40","author":"Nehme","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2022.104056_bib0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ebiom.2018.03.015","article-title":"The human cytomegalovirus strain DB activates oncogenic pathways in mammary epithelial cells","volume":"30","author":"Kumar","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2022.104056_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.772160","article-title":"Distinct oncogenic transcriptomes in human mammary epithelial cells infected with cytomegalovirus","volume":"12","author":"Haidar Ahmad","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2022.104056_bib0032","doi-asserted-by":"crossref","first-page":"7784","DOI":"10.4049\/jimmunol.0803800","article-title":"Bcl-3-regulated transcription from major immediate-early promoter of human cytomegalovirus in monocyte-derived macrophages","volume":"182","author":"Khan","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2022.104056_bib0033","doi-asserted-by":"crossref","first-page":"e59591","DOI":"10.1371\/journal.pone.0059591","article-title":"HCMV activates the IL-6-JAK-STAT3 Axis in HepG2 cells and primary human hepatocytes","volume":"8","author":"Lepiller","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ebiom.2022.104056_bib0034","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1084\/jem.20181276","article-title":"Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML","volume":"216","author":"Basheer","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2022.104056_bib0035","first-page":"51998","article-title":"The soft agar colony formation assay","author":"Borowicz","year":"2014","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ebiom.2022.104056_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004136","article-title":"The downregulation of GFI1 by the EZH2-NDY1\/KDM2B-JARID2 axis and by human cytomegalovirus (HCMV) associated factors allows the activation of the HCMV major IE promoter and the transition to productive infection","volume":"10","author":"Sourvinos","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2022.104056_bib0037","doi-asserted-by":"crossref","first-page":"12574","DOI":"10.1038\/s41598-018-30109-1","article-title":"The transcriptome of human mammary epithelial cells infected with the HCMV-DB strain displays oncogenic traits","volume":"8","author":"Moussawi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2022.104056_bib0038","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/onc.2013.96","article-title":"Generation of cancer stem-like cells through the formation of polyploid giant cancer cells","volume":"33","author":"Zhang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2022.104056_bib0039","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C T method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ebiom.2022.104056_bib0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/vaccines7030070","article-title":"Human cytomegalovirus cell tropism and host cell receptors","volume":"7","author":"Gerna","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ebiom.2022.104056_bib0041","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.1689075","article-title":"Activation of proto-oncogenes: an immediate early event in human cytomegalovirus infection","volume":"247","author":"Boldogh","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2022.104056_bib0042","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1038\/onc.2017.72","article-title":"Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells","volume":"36","author":"Niu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2022.104056_bib0043","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/sj.bjc.6605333","article-title":"Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis","volume":"101","author":"Fluge","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ebiom.2022.104056_bib0044","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1038\/onc.2016.453","article-title":"TRIM28 interacts with EZH2 and SWI\/SNF to activate genes that promote mammosphere formation","volume":"36","author":"Li","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2022.104056_bib0045","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13046-015-0277-8","article-title":"The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer","volume":"34","author":"Fei","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2022.104056_bib0046","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/bjc.2011.551","article-title":"The role of EZH2 in tumour progression","volume":"106","author":"Chang","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ebiom.2022.104056_bib0047","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/1947601910378691","article-title":"MYC and breast cancer","volume":"1","author":"Xu","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ebiom.2022.104056_bib0048","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/s41598-019-39122-4","article-title":"Genome-wide expression analysis reveals six contravened targets of EZH2 associated with breast cancer patient survival","volume":"9","author":"Kumari","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2022.104056_bib0049","article-title":"Overexpression of EZH2\/NSD2 histone methyltransferase axis predicts poor prognosis and accelerates tumor progression in triple-negative breast cancer","volume":"10","author":"Gao","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ebiom.2022.104056_bib0050","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.1038\/s41388-020-01484-9","article-title":"EZH2 overexpression dampens tumor-suppressive signals via an EGR1 silencer to drive breast tumorigenesis","volume":"39","author":"Guan","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2022.104056_bib0051","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1158\/0008-5472.CAN-19-3326","article-title":"The EZH2\u2013PHACTR2\u2013AS1\u2013ribosome axis induces genomic instability and promotes growth and metastasis in breast cancer","volume":"80","author":"Chu","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2022.104056_bib0052","doi-asserted-by":"crossref","first-page":"98348","DOI":"10.18632\/oncotarget.21311","article-title":"The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2022.104056_bib0053","doi-asserted-by":"crossref","first-page":"e52483","DOI":"10.7554\/eLife.52483","article-title":"Dissecting transcriptional amplification by MYC","volume":"9","author":"Nie","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.ebiom.2022.104056_bib0054","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cell.2012.08.033","article-title":"c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells","volume":"151","author":"Nie","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2022.104056_bib0055","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1182\/blood-2008-03-147645","article-title":"MYC stimulates EZH2 expression by repression of its negative regulator miR-26a","volume":"112","author":"Sander","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2022.104056_bib0056","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41388-018-0459-x","article-title":"miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer","volume":"38","author":"Sun","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2022.104056_bib0057","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/1535-7163.MCT-15-0750","article-title":"BRD4 regulates EZH2 transcription through upregulation of C-MYC and represents a novel therapeutic target in bladder cancer","volume":"15","author":"Wu","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ebiom.2022.104056_bib0058","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/biom7030053","article-title":"MYC-driven pathways in breast cancer subtypes","volume":"7","author":"Fallah","year":"2017","journal-title":"Biomolecules"},{"key":"10.1016\/j.ebiom.2022.104056_bib0059","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/neup.12534","article-title":"Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high-MYC medulloblastoma","volume":"39","author":"Natsumeda","year":"2019","journal-title":"Neuropathology"},{"key":"10.1016\/j.ebiom.2022.104056_bib0060","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1128\/MCB.19.8.5339","article-title":"c-Myc overexpression uncouples DNA replication from mitosis","volume":"19","author":"Li","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ebiom.2022.104056_bib0061","doi-asserted-by":"crossref","first-page":"75235","DOI":"10.18632\/oncotarget.12118","article-title":"Somatic polyploidy is associated with the upregulation of c-MYC interacting genes and EMT-like signature","volume":"7","author":"Vazquez-Martin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2022.104056_bib0062","first-page":"3627","article-title":"Correlation of c-myc expression with nuclear pleomorphism in human renal cell carcinoma","volume":"49","author":"Kinouchi","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2022.104056_bib0063","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.celrep.2018.12.071","article-title":"p53 Loss in breast cancer leads to myc activation, increased cell plasticity, and expression of a mitotic signature with prognostic value","volume":"26","author":"Santoro","year":"2019","journal-title":"Cell Reports"},{"key":"10.1016\/j.ebiom.2022.104056_bib0064","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1093\/emboj\/cdg542","article-title":"EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer","volume":"22","author":"Bracken","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.ebiom.2022.104056_bib0065","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08975","article-title":"Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis","volume":"464","author":"Gupta","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2022.104056_bib0066","doi-asserted-by":"crossref","first-page":"E869","DOI":"10.3390\/pathogens9110869","article-title":"Regulation of the MIE locus during HCMV latency and reactivation","volume":"9","author":"Dooley","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.ebiom.2022.104056_bib0067","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/s42003-021-02889-2","article-title":"GFI1 tethers the NuRD complex to open and transcriptionally active chromatin in myeloid progenitors","volume":"4","author":"Helness","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.ebiom.2022.104056_bib0068","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.591099","article-title":"Multifaceted actions of GFI1 and GFI1B in hematopoietic stem cell self-renewal and lineage commitment","volume":"11","author":"Beauchemin","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.ebiom.2022.104056_bib0069","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001342","article-title":"An E2F1-mediated DNA damage response contributes to the replication of human cytomegalovirus","volume":"7","author":"E","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2022.104056_bib0070","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.cell.2008.12.043","article-title":"EZH2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells","volume":"136","author":"Ezhkova","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2022.104056_bib0071","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1071\/RD13169","article-title":"EZH2 is essential for development of mouse preimplantation embryos","volume":"26","author":"Huang","year":"2014","journal-title":"Reprod Fertil Dev"},{"key":"10.1016\/j.ebiom.2022.104056_bib0072","doi-asserted-by":"crossref","first-page":"10657","DOI":"10.1158\/0008-5472.CAN-07-2498","article-title":"A polycomb repression signature in metastatic prostate cancer predicts cancer outcome","volume":"67","author":"Yu","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2022.104056_bib0073","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/bcr2871","article-title":"EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells","volume":"13","author":"Stefansson","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ebiom.2022.104056_bib0074","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/MCB.06148-11","article-title":"Myc regulates the transcription of the PRC2 gene to control the expression of developmental genes in embryonic stem cells","volume":"32","author":"Neri","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ebiom.2022.104056_bib0075","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1158\/0008-5472.CAN-16-3452","article-title":"MYC inhibition depletes cancer stem-like cells in triple-negative breast cancer","volume":"77","author":"Yang","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2022.104056_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/cell.2010.0052","article-title":"EZH2 expression in astrocytes induces their dedifferentiation toward neural stem cells","volume":"13","author":"Sher","year":"2010","journal-title":"Cell Reprogr"},{"key":"10.1016\/j.ebiom.2022.104056_bib0077","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.celrep.2016.11.032","article-title":"Deletion of the polycomb-group protein EZH2 leads to compromised self-renewal and differentiation defects in human embryonic stem cells","volume":"17","author":"Collinson","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2022.104056_bib0078","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20151136","article-title":"Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis","volume":"213","author":"Shimizu","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2022.104056_bib0079","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1158\/1535-7163.MCT-13-0773","article-title":"Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-hodgkin lymphoma","volume":"13","author":"Knutson","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ebiom.2022.104056_bib0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.stem.2013.10.001","article-title":"Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner","volume":"14","author":"Xie","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ebiom.2022.104056_bib0081","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1038\/onc.2012.390","article-title":"EZH2 promotes a bi-lineage identity in basal-like breast cancer cells","volume":"32","author":"Granit","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ebiom.2022.104056_bib0082","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-016-0561-z","article-title":"STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer","volume":"15","author":"Pan","year":"2016","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ebiom.2022.104056_bib0083","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1158\/0008-5472.CAN-10-1933","article-title":"Histone methyltransferase EZH2 induces akt-dependent genomic instability and BRCA1 inhibition in breast cancer","volume":"71","author":"Gonzalez","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2022.104056_bib0084","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1227604","article-title":"EZH2 oncogenic activity in castration-resistant prostate cancer cells is polycomb-independent","volume":"338","author":"Xu","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2022.104056_bib0085","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ccr.2013.04.008","article-title":"Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells","volume":"23","author":"Kim","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2022.104056_bib0086","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/ncb2585","article-title":"E2F8 is essential for polyploidization in mammalian cells","volume":"14","author":"Pandit","year":"2012","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ebiom.2022.104056_bib0087","first-page":"19","article-title":"Physiological regulation of Akt activity and stability","volume":"2","author":"Liao","year":"2010","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.ebiom.2022.104056_bib0088","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1038\/oncsis.2016.75","article-title":"Linking genomic reorganization to tumor initiation via the giant cell cycle","volume":"5","author":"Niu","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ebiom.2022.104056_bib0089","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10585-019-09958-1","article-title":"The role of heterogeneous environment and docetaxel gradient in the emergence of polyploid, mesenchymal and resistant prostate cancer cells","volume":"36","author":"Lin","year":"2019","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.ebiom.2022.104056_bib0090","first-page":"1","article-title":"Asymmetric cell division in polyploid giant cancer cells and low eukaryotic cells","volume":"2014","author":"Zhang","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ebiom.2022.104056_bib0091","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/0008-5472.CAN-17-1861","article-title":"A distinct oncogenerative multinucleated cancer cell serves as a source of stemness and tumor heterogeneity","volume":"78","author":"D\u00edaz-Carballo","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2022.104056_bib0092","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00478-18","article-title":"Regulation of epstein-barr virus life cycle and cell proliferation by histone H3K27 methyltransferase EZH2 in Akata cells","volume":"3","author":"Ichikawa","year":"2018","journal-title":"MSphere"},{"key":"10.1016\/j.ebiom.2022.104056_bib0093","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41579-019-0249-7","article-title":"Latency and lytic replication in Epstein\u2013Barr virus-associated oncogenesis","volume":"17","author":"M\u00fcnz","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2022.104056_bib0094","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1172\/JCI40567","article-title":"KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine","volume":"120","author":"Ganem","year":"2010","journal-title":"J Clin Investig"},{"key":"10.1016\/j.ebiom.2022.104056_bib0095","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1038\/s41467-021-26502-6","article-title":"Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes","volume":"12","author":"Lehmann","year":"2021","journal-title":"Nat Commun"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422002377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422002377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:14:17Z","timestamp":1762456457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422002377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":95,"alternative-id":["S2352396422002377"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104056","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104056"}}